← All stocks

Stablecoin Development Corp

SDEV Net selling
CIK 0001389545 #4652 in the set updated 21 Sep 2026
Bought (120 mo)
$834.98K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.55M
$0.00 on a plan · $107.83K straight out of an exercise
Sold at will
$3.44M
11 of 15 sales
Net
−$2.71M
−$2.61M against sales at will

By person

19 insiders · 73 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fu Jian Ping
10% owner
$3.06M (2)
−$3.06M
4,000,000
$4.36M
−12.8%
POPLAR POINT CAPITAL PARTNERS LP entity
10% owner
$313.79K (36)
+$313.79K
1,020,300
$1.11M
+96.9%
WU MIJIA
Director
$187.79K (3)
−$187.79K
1,716
$1.87K
−90.7%
Kunin Audrey
Chief Product Officer
$234.84K (6)
$58.64K (3)
+$176.20K
0
$0.00
Kunin Jeffrey
President, DERMAdoctor, LLC
$234.84K (6)
$58.64K (3)
+$176.20K
0
$0.00
Pioneer Pharma (Hong Kong) Co Ltd entity
10% owner
$98.28K (1)
−$98.28K
5,188,421
$5.66M
−0.5%
Hall Justin
CEO, GC and Director
$31.50K (2)
+$31.50K
83,172
$90.66K
+2,343%
Framework Ventures IV L.P. entity
10% owner
$26.94K (1) scheduled
−$26.94K
22,668,516
$24.71M
Kazley Michael John
Chief Executive Officer
$26.94K (1) scheduled
−$26.94K
22,668,516
$24.71M
R01 Fund LP entity
10% owner
$26.94K (1) scheduled
−$26.94K
22,668,516
$24.71M
Jones Andrew D.
CFO
$20.00K (2)
+$20.00K
127,461
$138.93K
−20.3%
Lazar David E.
10% owner
6,388,000
$6.96M
Pioneer Pharma (Singapore) Pte. Ltd. entity
10% owner
3,879,519
$4.23M
+62.4%
SIECZKAREK MARK M
Director
1,156,883
$1.26M
+61.7%
Sit Swan
Director
1,716
$1.87K
Freiman Paul E.
Director
1,716
$1.87K
Zheng Yenyou
Director
1,716
$1.87K
Garlikov Julie
Director
858
$935.22
Zheng Yongxiang
Director
858
$935.22

No percentages here. This company's share count has moved by a factor of 25.8 over the window, from 4,885,693 to 126,010,749 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 138
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 214,068,474
Sales filed before the plan box existed 11
History held since 26 Sep 2016